Jolanda Howe insider trades: Mirum Pharmaceuticals (MIRM) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jolanda reports to the SEC
Open-market buys and sales
23 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | MIRM | ↓ Sell | 658 | $100.00 | $66K | Direct | Sep 3, 2026 (1d) |
| Aug 18, 2026 | MIRM | ↓ Sell | 40,000 | $100.00 | $4.0M | Direct | Aug 19, 2026 (1d) |
| Aug 3, 2026 | MIRM | ↓ Sell | 1,840 | $105.29 | $194K | Direct | Aug 5, 2026 (2d) |
| Jul 1, 2026 | MIRM | ↓ Sell | 2,721 | $120.00 | $327K | Direct | Jul 2, 2026 (1d) |
| Jun 17, 2026 | MIRM | ↓ Sell | 2,594 | $101.95 | $264K | Direct | Jun 18, 2026 (1d) |
| Mar 16, 2026 | MIRM | ↓ Sell | 4,732 | $91.98 | $435K | Direct | Mar 17, 2026 (1d) |
| Feb 2, 2026 | MIRM | ↓ Sell | 968 | $103.30 | $100K | Direct | Feb 3, 2026 (1d) |
| Jan 26, 2026 | MIRM | ↓ Sell | 842 | $96.19 | $81K | Direct | Jan 27, 2026 (1d) |
| Jan 22, 2026 | MIRM | ↓ Sell | 926 | $93.33 | $86K | Direct | Jan 23, 2026 (1d) |
| Aug 7, 2025 | MIRM | ↓ Sell | 10,000 | $58.00 | $580K | Direct | Aug 8, 2025 (1d) |
| Jul 3, 2025 | MIRM | ↓ Sell | 1,041 | $48.63 | $51K | Direct | Jul 3, 2025 (0d) |
| Mar 18, 2025 | MIRM | ↓ Sell | 2,415 | $44.45 | $107K | Direct | Mar 19, 2025 (1d) |
| Mar 17, 2025 | MIRM | ↓ Sell | 57,606 | $44.35 | $2.6M | Direct | Mar 18, 2025 (1d) |
| Feb 3, 2025 | MIRM | ↓ Sell | 1,064 | $48.22 | $51K | Direct | Feb 4, 2025 (1d) |
| Jan 24, 2025 | MIRM | ↓ Sell | 902 | $47.92 | $43K | Direct | Jan 27, 2025 (3d) |
| Jan 7, 2025 | MIRM | ↓ Sell | 750 | $42.82 | $32K | Direct | Jan 8, 2025 (1d) |
| Nov 14, 2024 | MIRM | ↓ Sell | 2,500 | $47.10 | $118K | Direct | Nov 15, 2024 (1d) |
| Jul 2, 2024 | MIRM | ↓ Sell | 375 | $34.00 | $13K | Direct | Jul 3, 2024 (1d) |
| Feb 2, 2024 | MIRM | ↓ Sell | 735 | $26.19 | $19K | Direct | Feb 2, 2024 (0d) |
| Jan 8, 2024 | MIRM | ↓ Sell | 528 | $28.04 | $15K | Direct | Jan 9, 2024 (1d) |
| Dec 5, 2023 | MIRM | ↓ Sell | 2,500 | $32.40 | $81K | Direct | Dec 6, 2023 (1d) |
| Aug 25, 2023 | MIRM | ↓ Sell | 3,459 | $26.23 | $91K | Direct | Aug 28, 2023 (3d) |
| Jul 3, 2023 | MIRM | ↓ Sell | 915 | $25.65 | $23K | Direct | Jul 5, 2023 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other MIRM insiders
Open-market trades in the last 12 months
About Jolanda Howe's insider trades
Jolanda Howe is SVP, Global Controller at Mirum Pharmaceuticals (MIRM). Since Jul 3, 2023, Jolanda has reported no open-market purchases and 23 sales worth $9.3M on SEC Form 4. In the last 12 months: 9 sales ($5.6M).
Their filings also include option exercises (18 filings), grants and awards (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MIRM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.